BOWEL DISORDERS

BOWEL DISORDERS:

• 2024
• High Cannabigerol hemp extract moderates colitis and modulates the microbiome in an Inflammatory Disease bowel model. https://pubmed.ncbi.nlm.nih.gov/39009468/ 
• Meta-analysis of the Therapeutic impact of Cannabinoids in Inflammatory Bowel Disease. https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izae158/7743320 
• Cannabis and Stomach Pain: https://realmofcaring.org/cannabis-and-stomach-pain/?utm_source=Klaviyo&utm_medium=campaign&utm_campaign=08%2F08%20Cannabis%20and%20Stomach%20Pain&_kx=pQ9r0zLSMIUHWYqd0TqbvxV_DAPx16hhlJ43MlrVzik.UvV543
• Therapeutics effects of Cannabinoids on Ulcerative Colitis: A systematic review and meta analysis of Randomized Controlled Trials. https://jhsmr.org/index.php/jhsmr/article/view/1041 
• 2023
• A Randomized, controlled trial of efficacy and safety of cannabidiol in idiopathic and diabetic gastroparesis. https://pubmed.ncbi.nlm.nih.gov/37482172/ 
• 2022:
• Impact of Cannabis use on Inpatient inflammatory bowel disease outcomes in 2 states legalizing recreational cannabis. https://academic.oup.com/crohnscolitis360/article/4/2/otac015/6576191?login=false  
• The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. (2022) https://www.tandfonline.com/doi/full/10.1080/17474124.2022.2161046 
• Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment: https://www.frontiersin.org/articles/10.3389/fnins.2020.00371/full
• Can cannabis help with Crohn’s disease? Doctors and patients weigh in:  https://www.leafly.com/news/health/cannabis-and-crohns-disease?utm_source=SailThru&utm_medium=email_news&utm_campaign=Newsletters_11062019_Wed&utm_content=A&utm_term=%5BTWS%5D%20%26%20%5BMaster%20%2B%20Not%20Dormant%5D
• CBD and Constipation: https://www.cbdbreaker.com/faq/cbd-and-constipation/
• Endocannabinoid System in Irritable Bowel Syndrome and Cannabis as a therapy:  https://www.sciencedirect.com/science/article/abs/pii/S0965229919310179?via%3Dihub
• 2020
• Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience. (USA, full, 2020) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970440/ 
• Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. (Austria/ Germany, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31899693/ 
• 2019
• The Endocannabinoid System and the Gut. (news – 2019)
  https://todayspractitioner.com/cannabis/the-endocannabinoid-system-and-the-gut/
• Marijuana Flower Offers More Pain Relief Than Other Cannabis Products, Study Finds  (news–2019) https://www.marijuanamoment.net/marijuana-flower-offers-more-pain-relief-than-other-cannabis-products-study-finds/
• Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes. (USA, full, 2019) https://www.frontiersin.org/articles/10.3389/fimmu.2019.00914/full 
• Nabilone administration in refractory chronic diarrhea: a case series. (Italy, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/ 
• Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642200/ 
• Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders. (Canada/ Germany, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507278/ 
• In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States. (USA, full, 2019) http://atm.amegroups.com/article/view/25637/24217 
• Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics. (Spain/ Portugal, full, 2019) https://www.jmir.org/2019/8/e12610/ 
• Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency mediated chronic pain. (Italy/ Canada, full, 2019) https://www.sciencedirect.com/science/article/pii/S0889159118312479?via%3Dihub 
• Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. (Austria/ Germany, full, 2019) https://www.nature.com/articles/s41598-019-38865-4 
• Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome. (Canada/ Italy, full, 2019) https://www.mdpi.com/2072-6643/11/8/1956/htm 
• Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. (Belgium/ France/ Netherlands/ Canada/ Italy, full, 2019) https://www.nature.com/articles/s41467-018-08051-7 
• Insights into the role of cannabis in the management of inflammatory bowel disease. (Canada, full, 2019) https://journals.sagepub.com/doi/full/10.1177/1756284819870977 
• Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota. (USA, full, 2019) https://www.mdpi.com/2072-6643/11/1/117/htm 
• A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. (Norway/ Sweden, full, 2019) https://academic.oup.com/ibdjournal/article/25/3/490/5198657 
• New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota. (Iran, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203867/ 
• Gut microbiota: a new path to treat obesity. (Italy, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683132/ 
• Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. (Poland/ Germany, full, 2019) https://www.jgld.ro/jgld/index.php/jgld/article/view/265/167 
• Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet Induced Obesity in Mice. (Canada/ Italy, full, 2019) https://msystems.asm.org/content/4/6/e00407-19 
• Opportunities for cannabis in supportive care in cancer. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676264/ 
• Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications. (UK, full, 2019) https://www.oarsijournal.com/article/S1063-4584(19)31154-9/fulltext 
• Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response. (Mexico, full, 2019) https://www.nature.com/articles/s41598-019-56653-y 
• Association between cannabis use and complications related to ulcerative colitis in hospitalized patients: A propensity matched retrospective cohort study. (USA, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708902/ 
• The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health. (Greece, full, 2019) https://trugen3.com/the-important-role-of-the-endocannabinoid-system-and-the-endocannabinoidome-in-gut-health/ 
• Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys. (Switzerland/ USA, full, 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303113?via%3Dihub 
• Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease? (Israel, full, 2019) https://link.springer.com/article/10.1007%2Fs10620-019-05763-8 
• Cannabis for Inflammatory Bowel Diseases: Should We Follow the Wisdom of the Crowd? (Israel, download full, 2019) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=11&page=756
• Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome. (China, full, 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.13555 
• Association Between Cannabis Use and Complications Related to Crohn’s Disease: A Retrospective Cohort Study. (USA, link to PDF, 2019) https://www.researchgate.net/publication/331469237_Association_Between_Cannabis_Use_and_Complications_Related_to_Crohn%27s_Disease_A_Retrospective_Cohort_Study 
• The Gut Microbiome Influences Host Endocrine Functions. (Belgium/ France, click “open access”, then “academicoupcom” for download, 2019) https://www.semanticscholar.org/paper/The-gut-microbiome-influences-host-endocrine-Rastelli-Cani/a3bbea1016824ccbdc8bcf868845d89cda6a38cc 
• Use of Medical Cannabis in Patients With Inflammatory Bowel Disease. (USA, interview, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366240/ 
• Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases. (USA, abstract, 2019) https://link.springer.com/article/10.1007%2Fs11894-019-0670-0 
• A body packer with cannabis. (Netherlands, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30719888/ 
• Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting. (South Africa, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30720344/ 
• Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30801394/ 
• Patterns of Marijuana Use Among Patients With Celiac Disease in the United States: A Population-based Analysis of the NHANES Survey. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31339867/ 
• Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. (Canada, abstract, 2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/da.22947 
• Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0889159119306476?via%3Dihub 
• Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα. (UK/ Ireland, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0006295219302722?via%3Dihub 
• Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. (China, abstract, 2019) https://www.clinicalnutritionjournal.com/article/S0261-5614(19)30231-6/fulltext 
• The effectiveness of self-directed medical cannabis treatment for pain. (USA, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919308040 
• Role of the endocannabinoidome in human and mouse atherosclerosis. (Canada/ Italy, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31448709/ 
• Cannabis use and risk of Clostridioides difficile infection: Analysis of 59,824 hospitalizations. (USA/ Canada, abstract, 2019) https://www.sciencedirect.com/science/article/pii/S1075996419301556?via%3Dihub 
• The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients. (Italy/ Canada/ Malta, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S1043661819311077?via%3Dihub 
• Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31567639/ 
• The curative effect of cannabinoid 2 receptor agonist on functional failure and disruptive inflammation caused by intestinal ischemia and reperfusion. (Turkey, abstract, 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/fcp.12502 
• Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. (Canada/ Belgium, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31690638/ 
• Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31725152/ 
• Relationship Between Recreational Marijuana Use and Bowel Function in a Nationwide Cohort Study. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31764090/ 
• The curative effect of a cannabinoid 2 receptor agonist on functional failure and disruptive inflammation caused by intestinal ischemia and reperfusion. (Canada, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31774568/ 
• The gut microbiota modulates both browning of white adipose tissue and the activity of brown adipose tissue. (Spain, abstract, 2019) https://link.springer.com/article/10.1007/s11154-019-09523-x 
• Cannabinoids: A Guide for Use in the World of Gastrointestinal Disease. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31789770/ 
• Effects of O-1602 and CBD on TNBS-induced colonic disturbances. (China, abstract, 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13756 
• Cannabinoids and the Microbiota-Gut-Brain-Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders. (USA, abstract, 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/acer.14256 
• 2018
• Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease. (USA, full + video, 2018)https://academic.oup.com/ibdjournal/article/24/11/2309/4999337 
• Cannabis for the treatment of ulcerative colitis. (Canada, full in English & Spanish, 2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012954.pub2/full 
• Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach. (China/ Hong Kong, full, 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00270/full 
• The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. (Germany, full, 2018) https://www.mdpi.com/2076-3271/6/2/32/htm 
• Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders (France/ Belgium, full, 2018) https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22175 
• Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats. (Japan, full, 2018) https://www.sciencedirect.com/science/article/pii/S1347861318301002?via%3Dihub 
• The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111500/ 
• Attenuation of Listeria monocytogenes Virulence by Cannabis sativa L. Essential Oil. (Italy, full, 2018) https://www.frontiersin.org/articles/10.3389/fcimb.2018.00293/full
• Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. (Austria, full, 2018) https://link.springer.com/article/10.1007/s00418-018-1719-0 
• Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis. (USA/ UK, full, 2018) https://www.jci.org/articles/view/96817 
• Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. (USA, full, 2018) https://www.jpeds.com/article/S0022-3476(18)30388-3/fulltext 
• Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? (UK/ USA, full, 2018) https://academic.oup.com/ibdjournal/article/24/10/2123/5055343 
• Cannabis, cannabinoids and the endocannabinoid system – is there therapeutic potential for inflammatory bowel disease? (UK, full, 2018) https://academic.oup.com/ecco-jcc/article/13/4/525/5173479 
• Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150799/ 
• Host and helminth-derived endocannabinoids are generated during infection with effects on host immunity. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204704/ 
• Plasma endocannabinoid levels in lean, overweight and obese humans: relationships with intestinal permeability markers, inflammation and incretin secretion. (Australia/ USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230711/ 
• Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246979/ 
• Acute inflammation: endogenous cannabinoids mellow the harsh proinflammatory environment. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118573/ 
• miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus–Infected Rhesus Macaques. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893401/ 
• Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692862/ 
• The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation. (USA, full, 2018) https://academic.oup.com/ibdjournal/article/25/3/427/5144402 
• The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. (UK, link to PDF, 2018) https://www.researchgate.net/publication/322738763_The_Use_of_Cannabinoids_in_Colitis_A_Systematic_Review_and_Meta-Analysis 
• Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors. (Japan, link to PDF, 2018) https://www.researchgate.net/publication/323953296_Mechanisms_underlying_the_effects_of_n-3_polyunsaturated_fatty_acids_on_fear_memory_processing_and_their_hypothetical_effects_on_fear_of_cancer_recurrence_in_cancer_survivors 
• Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease. (USA, link to PDF, 2018) https://www.researchgate.net/publication/259628562_A_Review_of_the_Use_of_Complementary_and_Alternative_Medicines_by_Children_with_Inflammatory_Bowel_Disease 
• Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells. (Sweden, click “uclouvainbe” for download, 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Interferon+%CE%B3+treatment+increases+endocannabinoid+and+related+N-acylethanolamine+levels+in+T84+human+colon+carcinoma+cells.&btnG 
• Pharmacological modulation of colorectal distension evoked potentials in conscious rats. (Denmark/ Sweden, click “aaudk” for download, 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Pharmacological+modulation+of+colorectal+distension+evoked+potentials+in+conscious+rats&btnG 
• Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease. (USA, abstract, 2018) https://link.springer.com/article/10.1007%2Fs10620-018-5040-5 
• Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum. (Austria, abstract, 2018) https://www.semanticscholar.org/paper/Effect-of-CB1-Ligands-on-Neurogenic-and-Myogenic-in-Donnerer-Liebmann/f0bf75a2b4838b55aa038c707a34e2af223a466c 
• Cannabinoid receptor type 1 in the brain regulates the affective component of visceral pain in mice. (Germany, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306452218303919 
• The OEA effect on food intake is independent from the presence of PPARα in the intestine and the nodose ganglion, while the impact of OEA on energy expenditure requires the presence of PPARα in mice. (Switzerland/ Singapore, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0026049518301392 
• Cannabinoid pharmacology and therapy in gut disorders. (Spain, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186 
• Psychosis and synthetic cannabinoids. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0165178117314312?via%3Dihub 
• Endocannabinoids in the treatment of gastrointestinal inflammation and symptoms. (UK/ Italy, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S1471489218300183?via%3Dihub 
• The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. (USA/ Poland/ Germany, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0014299918304734?via%3Dihub 
• Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis. (Spain, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303630 
• Impact of recreational and medicinal marijuana on surgical patients: A review. (USA, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0002961018311231 
• 2017
• I made my son cannabis cookies. They changed his life. (news – 2017)
  https://www.washingtonpost.com/opinions/i-made-my-son-cannabis-cookies-they-changed-his-life/2017/01/06/699b1d20-d1ef-11e6-a783-cd3fa950f2fd_story.html?utm_term=.dd6a6531b7b2
• I’m 17, and Medical Marijuana Is Keeping Me Alive. (news – 2017)
  https://www.healthline.com/health/crohns-disease/medical-marijuana-keeping-me-alive#1
• Active ingredients in both hot peppers and cannabis calm the gut’s immune system.
  (news – 2017) https://medicalxpress.com/news/2017-04-ingredients-hot-peppers-cannabis-calm.html
• Chili peppers, marijuana may reduce gut inflammation. (news – 2017)
  https://www.medicalnewstoday.com/articles/317128.php
• To Calm the Gut, Look to Weed and Hot Peppers. (news – 2017)
  https://www.inverse.com/article/30714-marijuana-weed-spicy-food-gut
• These Digestive Diseases Are Being Treated With Medical Cannabis. (news – 2017)
  https://www.marijuanatimes.org/these-digestive-diseases-are-being-treated-with-medical-cannabis/
• Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat. (Spain, full, 2017) https://www.frontiersin.org/articles/10.3389/fphar.2017.00037/full 
• Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat. (Ireland/ Italy, full, 2017) https://www.nature.com/articles/srep43300 
• We are not alone: a case for the human microbiome in extra intestinal diseases. (India, full, 2017)https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0163-3 
• Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology? (Poland, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/ 
• Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells. (Italy, full, 2017) https://journals.sagepub.com/doi/full/10.1177/2050640617698622 
• Endocannabinoid system acts as a regulator of immune homeostasis in the gut. (USA, full, 2017) https://www.pnas.org/content/early/2017/04/18/1612177114.long 
• Host-probiotic interaction: new insight into the role of the endocannabinoid system by in vivo and ex vivo approaches. (Italy, full, 2017) https://www.nature.com/articles/s41598-017-01322-1 
• Interactions between gut microbes and host cells control gut barrier and metabolism. (Belgium, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485881/ 
• Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipiddependent gut transit in ApoE-/- mice. (Austria, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464855/ 
• Anti-Inflammatory Activity in Colon Models Is Derived from Δ9- Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts. (Israel, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/ 
• Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. (Canada/ USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/ 
• Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688117/ 
• Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. (China, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655955/ 
• Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid system protects against colitis and ameliorates remote organ lesions in mice. (China, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/ 
• Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature Review. (Israel, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748310/ 
• Nutritional status dependent endocannabinoid signalling regulates the integration of rat visceral information. (France, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451724/ 
• MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976484/ 
• Pharmacogenetics and the treatment of functional gastrointestinal disorders. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591464/ 
• Endocannabinoid-related compounds in gastrointestinal diseases. (Italy/ UK, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783846/ 
• Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial. (Israel, link to PDF, 2017) https://www.researchgate.net/publication/315703646_Low-Dose_Cannabidiol_Is_Safe_but_Not_Effective_in_the_Treatment_for_Crohn's_Disease_a_Randomized_Controlled_Trial 
• The role of CB1 in intestinal permeability and inflammation. (UK/ Ireland, link to PDF, 2017) https://www.researchgate.net/publication/316111984_The_role_of_CB1_in_intestinal_permeability_and_inflammation 
• Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). (Canada/ USA/ Poland/ Italy/ Germany/ Belgium/ France, request for PDF, 2017) https://www.researchgate.net/publication/318378715_Targeting_fatty_acid_amide_hydrolase_and_transient_receptor_potential_vanilloid-1_simultaneously_to_modulate_colonic_motility_and_visceral_sensation_in_the_mouse_A_pharmacological_intervention_with_N- 
• Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases. (Italy, link to PDF, 2017) https://www.researchgate.net/publication/313889347_Gut-brain_Axis_Role_of_Lipids_in_the_Regulation_of_Inflammation_Pain_and_CNS_Diseases 
• Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. (Italy, link to PDF, 2017) https://www.researchgate.net/publication/319590700_Antibiotic-induced_microbiota_perturbation_causes_gut_endocannabinoidome_changes_hippocampal_neuroglial_reorganization_and_depression_in_mice 
• Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. (Brazil, download, 2017) http://www.posnutricao.ufv.br/wp-content/uploads/2018/03/Impact-of-dietary-fat-on-gut-microbiota-and-lowgrade-systemic-inflammation-mechanisms-and-clinical-implications-on-obesity.pdf 
• Modulation of the endocannabinoid system by the fatty acid amide hydrolase, monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy. (Poland, link to download, 2017) http://www.jpp.krakow.pl/journal/archive/08_17/pdf/591_08_17_article.pdf 
• Cannabidiol and Palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. (UK, click “nottinghamacuk” for download, 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabidiol+and+palmitoylethanolamide+are+anti-inflammatory+in+the+acutely+inflamed+human+colon.%22&btnG 
• Textual research on Han-Chinese formulae collected in Tubo medical manuscript unearthed in 'Bum-pa-Che Tower. (China, abstract in English, 2017) https://pubmed.ncbi.nlm.nih.gov/28103984/ 
• The development of functional gastrointestinal diseases: Genetic aspects. (Russia, abstract in English & Russian, 2017) https://pubmed.ncbi.nlm.nih.gov/28635880/ 
• Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. (Austria/ Germany, abstract, 2017) https://link.springer.com/chapter/10.1007%2F164_2016_105 
• Role of cannabis in digestive disorders. (USA/ India, abstract, 2017) https://www.semanticscholar.org/paper/Role-of-cannabis-in-digestive-disorders-Goyal-Singla/232a2b4bf1a1211f32a299f735c94c5e6a272b44 
• Cannabinoids as gastrointestinal anti-inflammatory drugs. (Poland, abstract, 2017) https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13038 
• G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis. (Poland, abstract, 2017) https://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20& 
• The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. (USA, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S0376871617300881 
• Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? (Germany/ Austria, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/   
• 2016
• Japan’s First Lady Ushers In New Era of Hemp Acceptance by Purchasing Elixinol CBD Hemp Oil Product (news–2016) https://globenewswire.com/news-release/2016/07/08/854645/0/en/Japan-s-First-Lady-Ushers-In-New-Era-of-Hemp-Acceptance-by-Purchasing-Elixinol-CBD-Hemp-Oil-Product.html
• “try cannabis” (news–2016) http://slow-mixmary.blogspot.com/
• Cannabis as a Treatment for Inflammatory Bowel Disease. (news – 2016)
  https://www.marijuanatimes.org/cannabis-as-a-treatment-for-inflammatory-bowel-disease/ 
• Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. (Egypt, full, 2016) https://www.sciencedirect.com/science/article/pii/S1995764516300712 
• Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting. (India, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919975/ 
• Unusual side effect of cannabis use: acute abdomen due to duodenal perforation. (Turkey, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936980/ 
• Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment. (Canada/ Poland/ Germany, full, 2016) https://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-016-0129-0 
• Endocannabinoids in the Gut. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/ 
• Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature. (UK/ Pakistan, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040794/ 
• The CB2 receptor and its role as a regulator of inflammation. (Canada, full, 2016) https://link.springer.com/article/10.1007/s00018-016-2300-4 
• Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. (China, full, 2016) https://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm 
• Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859716/ 
• An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse. (Italy, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/ 
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/ 
• The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. (Iran, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056566/ 
• The role of the endocannabinoid system in the brain-gut axis. (Canada/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/ 
• Endocannabinoids in the gastrointestinal tract. (Republic of Korea/ USA, full, 2016) https://journals.physiology.org/doi/full/10.1152/ajpgi.00294.2015 
• RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. (Poland/ Germany/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916644/ 
• Role of cannabinoids in gastrointestinal mucosal defense and inflammation. (Hungary, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333598/ 
• Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250561/ 
• The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. (Austria/ Germany, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130148/ 
• Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα. (Ireland/ UK, full, 2016) https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.201500132 
• Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome. (Canada/ Italy/ Japan/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808772/ 
• Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885506/ 
• May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat. (Spain, full, 2016) https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.12952 
• Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (Israel, link to download PDF, 2016) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?aid=4045 
• Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study. (Taiwan, link to PDF, 2016) https://www.researchgate.net/publication/307599402_Determination_of_cannabinoids_in_hemp_nut_products_in_Taiwan_by_HPLC-MSMS_coupled_with_chemometric_analysis_Quality_evaluation_and_a_pilot_human_study 
• Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis. (USA, link to PDF, 2016) https://www.researchgate.net/publication/283729505_Dietary_Supplement_Therapies_for_Inflammatory_Bowel_Disease_Crohn's_Disease_and_Ulcerative_Colitis 
• Cannabis intake and intussusception: an accidental association? (Spain, link to download, 2016) http://scielo.isciii.es/pdf/diges/v109n2/nota_clinica3.pdf 
• Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany, abstract in English & German, 2016) https://link.springer.com/article/10.1007/s00482-015-0087-0 
• Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice. (China, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/26991932/ 
• MEDICAL CANNABIS. (Israel, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27215115/ 
• Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages. (Netherlands, abstract, 2016) https://www.semanticscholar.org/paper/Docosahexaenoyl-serotonin%2C-an-endogenously-formed-Poland-Klooster/a86aee234601d1f46a2b9e6ea8d1f3a6e21d90f8 
• Cannabinoids and GI Disorders: Endogenous and Exogenous. (USA, abstract, 2016) https://link.springer.com/article/10.1007/s11938-016-0111-1 
• Medical Cannabis - another piece in the mosaic of autoimmunity? (Israel, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27859024/ 
• Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis. (Iran, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S002432051630666X 
• The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis. (China/ Poland, abstract, 2016) https://link.springer.com/article/10.1007/s10620-016-4404-y 
• An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma. (Germany, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/26757305/ 
• 2015
• Cannabis Superior To Drugs For Inflammatory Bowel Condition (Crohn’s Disease) (news-2015) http://www.greenmedinfo.com/blog/cannabis-superior-drugs-inflammatory-bowel-condition-crohnsdisease
• What ailments does medical marijuana help? (news-2015) http://www.mnn.com/health/fitness-well-being/stories/what-ailments-does-medical-marijuana-help
• Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study. (Belgium, full, 2015) https://www.karger.com/Article/FullText/375454 
• Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. (Belgium/ France, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382707/ 
• Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid. (Turkey, full, 2015) https://www.wjgnet.com/1007-9327/full/v21/i37/10704.htm 
• Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol. (Canada, full, 2015) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144270 
• Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity. (Austria/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/ 
• Self-medication of achalasia with cannabis, complicated by a cannabis use disorder. (France, full, 2015) https://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm 
• A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway. (Japan/ Italy, full, 2015) https://www.jbc.org/content/290/5/2902.long 
• Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage. (USA/ Italy, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447230/ 
• AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner. (Canada/ USA/ Germany/ Taiwan, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/ 
• Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine. (Denmark, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600392/ 
• Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. (Canada/ USA/ Italy/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459026/ 
• The GPR55 antagonist CID16020046 protects against intestinal inflammation. (Austria/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587547/ 
• In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat. (Spain/ Germany/ China/ Poland/ USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918633/ 
• Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium. (UK, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101681/ 
• Endocannabinoid signaling at the periphery: 50 years after THC. (Italy/ Israel/ Hungary/ USA/ Qatar/ Canada/ Germany, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420685/ 
• Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644500/ 
• The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446691/ 
• No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. (Turkey, link to PDF, 2015) https://www.researchgate.net/publication/271537226_No_association_between_the_functional_cannabinoid_receptor_type_2_Q63R_variants_and_inflammatory_bowel_disease_in_Turkish_subjects 
• Endocannabinoids - at the crossroads between the gut microbiota and host metabolism. (Belgium, link to PDF, 2015) https://www.researchgate.net/publication/287327687_Endocannabinoids_-_at_the_crossroads_between_the_gut_microbiota_and_host_metabolism 
• The role of cannabinoids in regulation of nausea and vomiting, and visceral pain. (Canada/ USA, download, 2015) https://www.gastrojournal.org/article/S0016-5085(16)34319-0/pdf 
• Gastric mucosal protection: from the periphery to the central nervous system. (Hungary, link to download, 2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf 
• Pharmacogenetics in irritable bowel syndrome. (USA, link to download, 2015) https://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1048223 
• The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract. (Canada, click “researchgate” for download, 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+Endocannabinoid+System+and+Its+Role+in+Regulating+the+Intrinsic+Neural+Circuitry+of+the+Gastrointestinal+Tract.+++++++++++++++++&btnG 
• Endocannabinoids and the Digestive Tract and Bladder in Health and Disease. (UK, partial preview, 2015) https://books.google.com/books?hl=en&lr=&id=QwihCgAAQBAJ&oi=fnd&pg=PA392&ots=FMMqEBDUlA&sig=rRXLCR-WXtY956wHaCOJXuECrT0#v=onepage&q&f=false 
• The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. (Turkey, abstract, 2015) https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.12563 
• Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents. (China/ Poland, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/26254701/ 
• Cannabis - therapy for the future? (Czech Republic, abstract in English & link to abstract in Czech, 2015) https://pubmed.ncbi.nlm.nih.gov/26375695/ 
• The long-term functional consequences of acute infectious diarrhea. (Canada, abstract, 2015) https://www.semanticscholar.org/paper/The-long-term-functional-consequences-of-acute-Cocciolillo-Collins/0a91a2b9a713a79fc04f1873b0f4a4156709a790 
• Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis. (USA, abstract, 2015) https://www.sciencedirect.com/science/article/abs/pii/S0376871615016464 
• 2014
• Leaky Gut Syndrome: Cannabinoids and the Endocannabinoid System (ECS) as a therapeutic target (news–2014) https://www.sclabs.com/leaky-gut-syndrome-cannabinoids-and-the-endocannabinoid-system-ecs-as-a-therapeutic-target/
• L. Acidophilus and the CB2 Receptor (news–2014) https://www.sclabs.com/l-acidophilus-and-the-cb2-receptor/
• 2013
• Herbal medicine may ease constipation (news-2013) https://www.reuters.com/article/us-herbal-constipation/herbal-medicine-may-ease-constipation-idUSTRE6AB52320101112
• 2012
• Does Medical Marijuana Help Treat Diarrhea? (news-2012)  http://www.theweedblog.com/does-medical-marijuana-help-treat-diarrhea/
• 2011
• Marijuana Improves “Quality Of Life” For Patients With Inflammatory Bowel Disease (news–2011) http://www.theweedblog.com/marijuana-improves-quality-of-life-for-patients-with-inflammatory-bowel-disease/
• Medical marijuana for shingles. (news – undated)
  http://www.thetruthaboutshingles.com/2013/02/smoking-pot-no-help-for-shingles.html